SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-07-002041
Filing Date
2007-01-30
Accepted
2007-01-30 16:04:43
Documents
1
Period of Report
2007-01-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 22047
  Complete submission text file 0001140361-07-002041.txt   23982
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 210 CENTRAL PARK SOUTH NEW YORK NY 10019
KANZER STEVE H (Reporting) CIK: 0001076653 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 07564711